<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01584128</url>
  </required_header>
  <id_info>
    <org_study_id>38775EP</org_study_id>
    <nct_id>NCT01584128</nct_id>
  </id_info>
  <brief_title>Oxidized Regenerated Cellulose to Decrease Vaginal Cuff Complications</brief_title>
  <official_title>Use of Structured Non-woven Absorbable Hemostat (or Oxidized Regenerated Cellulose) to Decrease Vaginal Cuff Dehiscence Rate in Laparoscopic Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the investigators study is to determine whether the use of oxidized regenerated&#xD;
      cellulose reduces the risk of vaginal cuff cellulitis, pelvic abscess, or vaginal cuff&#xD;
      dehiscence in patients undergoing laparoscopic hysterectomy. The investigators hypothesize&#xD;
      that the use of oxidized regenerated cellulose will reduce the risk of vaginal cuff&#xD;
      cellulitis, pelvic abscess, and vaginal cuff dehiscence in patients undergoing laparoscopic&#xD;
      hysterectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Structured non-woven absorbable hemostat (or oxidized regenerated cellulose) was designed and&#xD;
      marketed for its hemostatic properties. It is used in our practice to achieve hemostasis at&#xD;
      the site of the vaginal cuff closure during laparoscopic hysterectomy. While the hemostatic&#xD;
      properties of oxidized regenerated cellulose are well known and documented, there is newer&#xD;
      research to suggest that oxidized regenerated cellulose may have antimicrobial activity. One&#xD;
      In vitro study investigated the antimicrobial activity of oxidized regenerated cellulose&#xD;
      products against multiple antibiotic resistant microorganisms and found that the&#xD;
      antimicrobial affect of the oxidized regenerated cellulose products was significantly greater&#xD;
      than that of the controls. There are a limited number of studies investigating the&#xD;
      antimicrobial activity of oxidized regenerated cellulose products in vivo (and none in&#xD;
      gynecologic surgery).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">March 1, 2013</completion_date>
  <primary_completion_date type="Actual">March 1, 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of vaginal cuff complications</measure>
    <time_frame>postoperative</time_frame>
    <description>Incidence of vaginal cuff complicationsincluding vaginal cuff dehiscence, vaginal cuff cellulitis, and vaginal cuff abscess</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>Vaginal Cuff Complications</condition>
  <arm_group>
    <arm_group_label>Oxidized regenerated cellulose</arm_group_label>
    <description>Patients undergoing laparoscopic hysterectomy who have oxidized regenerated cellulose placed at the vaginal cuff at the time of their surgery.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        women, age 20-80, undergoing laparoscopic hysterectomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female, ages 20-80, undergoing laparoscopic hysterectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  malignant indications for hysterectomy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carrie A Hossler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hershey Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>April 21, 2012</study_first_submitted>
  <study_first_submitted_qc>April 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2012</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

